Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200062848Phase 4Not yet recruiting
Phase 4, randomised trial of esketamine in postoperative pain and postpartum depression (PPD) (2 arms), sponsored by Pizhou People's Hospital. Primary endpoint: Numerical Rating Scale (NRS) pain score. Planned start Aug 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200062848.